NCAM as a target for GDNF-induced analgesia in neuropathic pain.
Sakai
Atsushi
A
Department of Pharmacology, Nippon Medical School, Sendagi, Bunkyo-ku, Tokyo, Japan.
Suzuki
Hidenori
H
D000698:Analgesia; D000818:Animals; D015195:Drug Design; D005727:Ganglia, Spinal / Q000378:metabolism; D015870:Gene Expression; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000502:physiology*; D019006:Neural Cell Adhesion Molecules / Q000235:genetics / Q000502:physiology*; D009437:Neuralgia / Q000188:drug therapy*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D015398:Signal Transduction
D051100:Glial Cell Line-Derived Neurotrophic Factor; D019006:Neural Cell Adhesion Molecules; D012333:RNA, Messenger